INLX Director Granted 4,500 Options at $12.88 – Routine Form 4
Intellinetics, Inc. (INLX) – Form 4 insider filing dated 06/25/2025 Director Paul Seid received a grant of 4,500 non-qualified stock options on 06/21/2025 at an exercise price of $12.88 per share.
Rhea-AI Filing Summary
Intellinetics, Inc. (INLX) – Form 4 insider filing dated 06/25/2025
Director Paul Seid received a grant of 4,500 non-qualified stock options on 06/21/2025 at an exercise price of $12.88 per share. The options were issued under the company’s 2023 Non-Employee Director Compensation Plan and expire on 06/20/2035. Following the award, Seid holds 10,500 derivative securities linked to INLX common stock. No shares were bought or sold, and no non-derivative positions were reported.
The transaction is routine director compensation and does not involve cash outlay, immediate share issuance, or a change in board composition.
Positive
- None.
Negative
- None.
Insights
TL;DR: Small routine option grant; minimal impact on valuation or float.
The filing records a standard equity incentive to a board member. The 4,500 options represent a negligible percentage of Intellinetics’ outstanding shares and are exercisable through 2035, creating no near-term dilution. Such grants are common governance practice to align director interests with shareholders. Because there were no open-market purchases or sales, the filing offers no directional signal on insider sentiment or company fundamentals. Investors should view it as administrative, with no material effect on liquidity, earnings, or strategic outlook.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Non-Qualified Stock Option | 4,500 | $0.00 | $0.00 |
Footnotes (1)
- F1. Granted in exchange for director services to the Company, in accordance with the Company's 2023 Non-Employee Director Compensation Plan.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction was reported for INLX on 06/25/2025?
How many derivative securities does the director hold after the transaction?
What is the expiration date of the newly granted options?
Under which plan were the options granted?
AI-generated analysis. How Rhea-AI works. Not financial advice.